tiprankstipranks
Corbus Pharmaceuticals (DE:337)
FRANKFURT:337

Corbus Pharmaceuticals (337) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Corbus Pharmaceuticals’s (337) Moving Averages Convergence Divergence (MACD) indicator is -0.76, suggesting Corbus Pharmaceuticals is a Buy.
Corbus Pharmaceuticals’s (337) 20-Day exponential moving average is 2.87, while Corbus Pharmaceuticals’s (337) share price is €0.132, making it a Sell.
Corbus Pharmaceuticals’s (337) 50-Day exponential moving average is 3.41, while Corbus Pharmaceuticals’s (337) share price is €0.132, making it a Sell.

Corbus Pharmaceuticals (337) Pivot Points

Apr 27, 2024, 06:10 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.12
0.13
0.13
0.13
0.13
0.14
0.14
Fibonacci
0.13
0.13
0.13
0.13
0.13
0.14
0.14
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Corbus Pharmaceuticals (337) Moving Averages

Apr 27, 2024, 06:10 AM
Period
Simple
Exponential
MA5
0.97Sell
1.00Sell
MA10
2.80Sell
2.05Sell
MA20
3.41Sell
2.87Sell
MA50
3.43Sell
3.41Sell
MA100
3.65Sell
4.03Sell
MA200
5.49Sell
5.75Sell
Corbus Pharmaceuticals’s (337) 10-Day exponential moving average is 2.05, while Corbus Pharmaceuticals’s (337) share price is €0.132, making it a Sell.
Corbus Pharmaceuticals’s (337) 100-Day exponential moving average is 4.03, while Corbus Pharmaceuticals’s (337) share price is €0.132, making it a Sell.
Corbus Pharmaceuticals’s (337) stock price is €0.132 and Corbus Pharmaceuticals’s (337) 50-day simple moving average is 3.43, creating a Sell signal.
Corbus Pharmaceuticals’s (337) stock price is €0.132 and Corbus Pharmaceuticals’s (337) 100-day simple moving average is 3.65, creating a Sell signal.
Corbus Pharmaceuticals’s (337) stock price is €0.132 and Corbus Pharmaceuticals’s (337) 200-day simple moving average is 5.49, creating a Sell signal.

Corbus Pharmaceuticals (337) Technical Indicators

Apr 27, 2024, 06:10 AM
Name
Value
Implied Action
RSI (14)
17.77
Buy
STOCH (9,6)
0.04
Buy
STOCHRSI (14)
0.04
Buy
MACD (12,26)
-0.76
Buy
ADX (14)
35.23
Neutral
Williams %R
-99.96
Buy
CCI (14)
-166.67
Buy
ATR (14)
0.36
-
Ultimate Oscillator
11.93
Sell
ROC
-96.62
Sell
Corbus Pharmaceuticals’s (337) Relative Strength Index (RSI) is 17.77, creating a Buy signal.
Corbus Pharmaceuticals’s (337) Trend Strength Indicator (ADX) is 35.23, creating a Neutral signal.
Corbus Pharmaceuticals’s (337) Commodity Channel Index (CCI) is -166.67, creating a Buy signal.
Corbus Pharmaceuticals’s (337) Price Rate of Change (ROC) is -96.62, creating a Sell signal.

FAQ

Is 337 a Buy, Hold, or Sell?
Based on 337’s technical indicators, 337 is a Sell.
    What is 337’s RSI (14)?
    337’s RSI (14) is 17.77, which suggests 337 is a Buy.
      What is 337’s MACD?
      337’s MACD is -0.76, which suggests 337 is a Buy.
        What is 337’s 5-day moving average?
        337’s 5-day moving average is 0.97, which suggests 337 is a Sell.
          What is 337’s 20-day moving average?
          337 20-day moving average is 3.41, which suggests 337 is a Sell.
            What is 337’s 50-day moving average?
            337’s 50-day moving average is 3.43, which suggests 337 is a Sell.
              What is 337’s 200-day moving average?
              337’s 200-day moving average is 5.49, which suggests 337 is a Sell.
                What is 337’s Williams % R (14)?
                337’s Williams % R (14) is -99.96, which suggests 337 is a Buy.
                  What is 337’s CCI (14)?
                  337’s CCI (14) is -166.67, which suggests 337 is a Buy.
                    What is the share price of Corbus Pharmaceuticals?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis